Suchergebnisse - "Bragadottir, Ragnheidur"

PubPharm (65)

1

Real-World Safety and Effectiveness of Voretigene Neparvovec : Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study

enthalten in: Biomolecules | 2024

von Fischer, M. | Simonelli, F. | Sahni, J. | +104

2

Macular hole Delphi consensus statement (MHOST)

enthalten in: Acta ophthalmologica | 2023

von Confalonieri, F. | Haave, H. | Binder, S. | +37

3

Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis : A prospective observational study

enthalten in: Acta ophthalmologica | 2023

von Blom, K. | Jørstad, �. | Faber, R. | +4

4

Vitreous Substitutes from Bench to the Operating Room in a Translational Approach : Review and Future Endeavors in Vitreoretinal Surgery

enthalten in: International journal of molecular sciences | 2023

von Confalonieri, F. | Josifovska, N. | Boix-Lemonche, G. | +4

5

Through the Eyes of Patients : Understanding Treatment Burden of Intravitreal Anti-VEGF Injections for nAMD Patients in Norway

enthalten in: Clinical ophthalmology (Auckland, N.Z.) | 2023

von Reitan, G. | Kjellevold Haugen, I. | Andersen, K. | +2

6

Intraoperative Optical Coherence Tomography in the Management of Macular Holes : State of the Art and Future Perspectives

enthalten in: Biomedicines | 2022

von Confalonieri, F. | Haave, H. | Bragadottir, R. | +4

7

Transition from Laser to Intravitreal Injections for Diabetic Retinopathy : Hospital Utilization and Costs from an Extended Healthcare Perspective

enthalten in: International journal of environmental research and public health | 2022

von Hertzberg, S. | Jørstad, �. | Petrovski, B. | +5

8

Mask use by patients in the context of COVID-19 can increase the risk of postinjection endophthalmitis

enthalten in: Acta ophthalmologica | 2022

von Blom, K. | Bragadóttir, R. | Sivertsen, M. | +2

9

Re : Writing committee for the Post-Injection Endophthalmitis Study Group, et al.: The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections (Ophthalmology. 2021;128:1620-1626)

enthalten in: Ophthalmology | 2022

von Blom, K. | Bragadóttir, R. | Sivertsen, M. | +2

CommentOn: Ophthalmology. 2021 Nov;128(11):1620-1626. - PMID 34019955

10

Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?

enthalten in: Ocular immunology and inflammation | 2022

von Blom, K. | Bragadóttir, R. | Sivertsen, M. | +2

1
2
3
4
5
6
7
Nächster »
[7]